Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Arctic Bioscience AS: Arctic Bioscience - Mandatory notification of trade

Arctic Bioscience
Download the release

Siglar AS, a legal person closely associated with a person discharging managerial responsibility in Arctic Bioscience, has today bought 20,000 shares in Arctic Bioscience at an average price of NOK 2,32 per share. Following the transaction, Siglar AS holds 20,000 shares in Arctic Bioscience. In addition, Siglar AS holds 50% ownership of Capra Invest AS, which holds 1,544,450 in Arctic Bioscience.

Chairman of the Board at Arctic Bioscience, Harald Nordal, is the owner of Siglar AS.

Please refer to the attached notification of trading for further details. 

This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 and the Norwegian Securities Trading Act § 5-12.

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.